Atrion Corporation (ATRI) |
459.92 0.26 (0.06%) 08-20 16:00 |
Open: | 459.75 |
High: | 460.26 |
Low: | 459.75 |
Volume: | 29,517 |
Market Cap: | 809(M) |
PE Ratio: | 64.5 |
Exchange: | NASDAQ Global Select |
Industry: | Medical - Instruments & Supplies |
Sector: | Healthcare |
Technical analysis | ||||
![]() |
||||
sell | buy |
Resistance 2: | 537.28 |
Resistance 1: | 460.00 |
Pivot price: | 459.75 |
Support 1: | 458.45 |
Support 2: | 457.50 |
52w High: | 503.24 |
52w Low: | 274.98 |
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
EPS | 7.130 |
Book Value | 135.720 |
PEG Ratio | 0.00 |
Gross Profit | 0.000 |
Profit Margin (%) | 6.92 |
Operating Margin (%) | 1.10 |
Return on Assets (ttm) | 4.0 |
Return on Equity (ttm) | 5.2 |
Fri, 09 Aug 2024
Atrion's (ATRI) Q2 Earnings Plummet Y/Y on Nordson Merger Costs - Yahoo Finance
Wed, 17 Jul 2024
User - FinancialContent
Tue, 28 May 2024
Nordson Corporation Announces Agreement to Acquire Atrion Corporation, a Market Leader in Medical Infusion and Cardiovascular Technologies - Business Wire
Tue, 28 May 2024
Nordson to bolster medical portfolio through $800 million acquisition - Crain's Cleveland Business
Fri, 10 May 2024
Atrion Corp (ATRI) Reports Mixed Q1 2024 Results Amid Revenue Growth and Margin Pressures - Yahoo Finance
Thu, 11 Apr 2024
3 Small Cap Dividend Stocks With Income And Growth - Barchart.com
![]() StockChart iOS |
![]() StoxlineLite iOS |
![]() StoxlineLite iOS |
![]() OptionCalc iOS |
![]() StockChart Android |
![]() StoxlineLite Android |
![]() StoxlinePro Android |
![]() OptionCalc Android |